Joseph E Payne - Net Worth and Insider Trading
Joseph E Payne Net Worth
The estimated net worth of Joseph E Payne is at least $36 Million dollars as of 2024-12-28. Joseph E Payne is the President and CEO of Arcturus Therapeutics Holdings Inc and owns about 1,480,097 shares of Arcturus Therapeutics Holdings Inc (ARCT) stock worth over $25 Million. Joseph E Payne is also the Director of Vallon Pharmaceuticals Inc and owns about 861,250 shares of Vallon Pharmaceuticals Inc (VLON) stock worth over $10 Million. Details can be seen in Joseph E Payne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph E Payne has not made any transactions after 2022-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph E Payne
Joseph E Payne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph E Payne owns 3 companies in total, including Arcturus Therapeutics Holdings Inc (ARCT) , Vallon Pharmaceuticals Inc (VLON) , and GRI Bio Inc (GRI) .
Click here to see the complete history of Joseph E Payne’s form 4 insider trades.
Insider Ownership Summary of Joseph E Payne
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARCT | Arcturus Therapeutics Holdings Inc | 2022-11-23 | director & 10 percent owner & President and CEO |
| VLON | Vallon Pharmaceuticals Inc | 2021-05-26 | director |
| GRI | GRI Bio Inc | 2021-05-14 | director |
Joseph E Payne Latest Holdings Summary
Joseph E Payne currently owns a total of 2 stocks. Among these stocks, Joseph E Payne owns 1,480,097 shares of Arcturus Therapeutics Holdings Inc (ARCT) as of November 23, 2022, with a value of $25 Million and a weighting of 70.91%. Joseph E Payne also owns 861,250 shares of Vallon Pharmaceuticals Inc (VLON) as of May 26, 2021, with a value of $10 Million and a weighting of 29.09%.
Latest Holdings of Joseph E Payne
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARCT | Arcturus Therapeutics Holdings Inc | 2022-11-23 | 1,480,097 | 17.02 | 25,191,251 |
| VLON | Vallon Pharmaceuticals Inc | 2021-05-26 | 861,250 | 12.00 | 10,335,000 |
Holding Weightings of Joseph E Payne
Joseph E Payne Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph E Payne has made a total of 2 transactions in Arcturus Therapeutics Holdings Inc (ARCT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Arcturus Therapeutics Holdings Inc is the acquisition of 5,000 shares on November 23, 2022, which cost Joseph E Payne around $82,550.
According to the SEC Form 4 filings, Joseph E Payne has made a total of 1 transactions in Vallon Pharmaceuticals Inc (VLON) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vallon Pharmaceuticals Inc is the acquisition of 17,500 shares on May 26, 2021, which cost Joseph E Payne around $71,750.
Insider Trading History of Joseph E Payne
- 1
Joseph E Payne Trading Performance
GuruFocus tracks the stock performance after each of Joseph E Payne's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph E Payne is 10.67%. GuruFocus also compares Joseph E Payne's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph E Payne within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph E Payne's insider trading performs compared to the benchmark.
Performance of Joseph E Payne
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.77 | | | | | |
| Relative Return to S&P 500(%) | 18.12 | | | | | |
Joseph E Payne Ownership Network
Joseph E Payne Owned Company Details
What does Arcturus Therapeutics Holdings Inc do?
Who are the key executives at Arcturus Therapeutics Holdings Inc?
Joseph E Payne is the director & 10 percent owner & President and CEO of Arcturus Therapeutics Holdings Inc. Other key executives at Arcturus Therapeutics Holdings Inc include Chief Scientific Officer & COO Pad Chivukula , Chief Financial Officer Andy Sassine , and See Remarks Keith C Kummerfeld .
Arcturus Therapeutics Holdings Inc (ARCT) Insider Trades Summary
Over the past 18 months, Joseph E Payne made no insider transaction in Arcturus Therapeutics Holdings Inc (ARCT). Other recent insider transactions involving Arcturus Therapeutics Holdings Inc (ARCT) include a net sale of 114,114 shares made by Pad Chivukula , a net sale of 50,000 shares made by Andy Sassine , and a net sale of 6,968 shares made by Keith C Kummerfeld .
In summary, during the past 3 months, insiders sold 12,000 shares of Arcturus Therapeutics Holdings Inc (ARCT) in total and bought 0 shares, with a net sale of 12,000 shares. During the past 18 months, 171,082 shares of Arcturus Therapeutics Holdings Inc (ARCT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 171,082 shares.
Arcturus Therapeutics Holdings Inc (ARCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcturus Therapeutics Holdings Inc Insider Transactions
Joseph E Payne Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph E Payne. You might contact Joseph E Payne via mailing address: 10628 Science Center Drive, Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
